Related Experiment Videos
Tripeptidyl peptidases: enzymes that count
1Dept of Biochemistry, Uppsala University, Biomedical Center, Box 576, SE-751 23 Uppsala, Sweden. Birgitta.Tomkinson@biokem.uu.se
Trends in Biochemical Sciences
|September 2, 1999
Summary
Cellular protein degradation relies on enzymes like tripeptidyl-peptidases I and II. Mutations in tripeptidyl-peptidase I are linked to neuronal ceroid lipofuscinosis, a lysosomal storage disease.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Biology
Background:
- Protein degradation is a fundamental cellular process, vital for cell survival and death.
- Proteins are broken down into amino acids by peptidases in lysosomes and the cytosol.
- Tripeptidyl-peptidases (TPPs) I and II are key exopeptidases releasing N-terminal tripeptides.
Purpose of the Study:
- To elucidate the role of tripeptidyl-peptidases in protein degradation pathways.
- To investigate the enzymatic activity of TPPs I and II in cleaving oligopeptides.
- To highlight the clinical relevance of TPPs, particularly TPP I.
Main Methods:
- Enzyme kinetics studies to characterize TPP I and TPP II activity.
- Analysis of protein degradation pathways in cellular models.
- Genetic analysis to identify mutations in TPP I.
Main Results:
- Tripeptidyl-peptidases I and II efficiently release tripeptides from oligopeptide substrates.
- Subsequent degradation of tripeptides by other exopeptidases yields amino acids and dipeptides.
- Mutations in tripeptidyl-peptidase I are identified as causative for late infantile neuronal ceroid lipofuscinosis.
Conclusions:
- Tripeptidyl-peptidases play a crucial role in the complete breakdown of proteins within the cell.
- Dysfunctional tripeptidyl-peptidase I leads to the accumulation of undegraded material, characteristic of lysosomal storage diseases.
- Understanding TPP function is critical for research into metabolic disorders and neurodegenerative diseases.